Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Diatranz Otsuka

Diatranz Otsuka?uq=K9LEA9hy
2011 FOUNDED
M&A STATUS
2ndary - Private LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of cellular therapies designed to improve the lives of people living with serious disease. The company's cellular therapies uses incredible biological similarities between humans and other mammals to develop therapies by using animal cells and tissues, enabling pharmaceutical companies to develop a breakthrough therapeutic option for a debilitating disease.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Otsuka Pharmaceutical Factory
Primary Office
  • PO Box 23 566
  • Auckland, 2155
  • New Zealand

+64 09-276 0000

Diatranz Otsuka Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Diatranz Otsuka‘s full profile, request access.

Request full access to PitchBook

Diatranz Otsuka Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Diatranz Otsuka‘s full profile, request access.

Request full access to PitchBook

Diatranz Otsuka Executive Team (1)

Name Title Board
Seat
Contact
Info
Shaun Wynyard General Manager